PTC Therapeutics, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 21 →InsidersNo open-market buys. 11 insiders sold $40.4M, all 154 sales on a 10b5-1 plan.→HoldersBlackRock 16.8%RTW Investments 9.3%Jupiter Topco 8.7%→PeersClosest companies: BBIO, MIRM, ROIV→
From the filings
Figures
- Revenue
- $1.01Blast 12 months
- Net income
- −$38.0Mlast 12 months
- Operating cash flow
- −$217.9Mlast 12 months
- Cash and equivalents
- $1.05Bat the last balance sheet
- Total debt
- $591.0Mat the last balance sheet
- Shares outstanding
- 83.3M shareson issue